Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.
about
sameAs
Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasisRole of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundiceCharacterisation of patients with a complete biochemical response to ursodeoxycholic acid.Portal vein bile acids in patients with severe inflammatory bowel diseaseWeight loss in primary biliary cirrhosisProperties and biological significance of the ileal bile salt transport system.Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy manOstα depletion protects liver from oral bile acid load.Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretionIsolation of a bile salt sulfatase-producing Clostridium strain from rat intestinal microflora.Nuclear receptors as therapeutic targets in cholestatic liver diseases.Bile Acid sulfation: a pathway of bile acid elimination and detoxification.Altered systemic bile acid homeostasis contributes to liver disease in pediatric patients with intestinal failure.The drug transporter OAT3 (SLC22A8) regulates endogenous metabolite flow through the gut-liver-kidney axis.Quantitative determination of serum bile acids using a 7alpha-hydroxysteroid dehydrogenase.Treatment of pruritus in cholestatic jaundice by bilirubin- and bile acid-adsorbing resin column plasma perfusion.Bile acid profiles in urine of patients with liver diseases.Serum bile acids in hepatobiliary disease.Systemic spill-over of bile acids.Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MSThe Sea Lamprey as an Etiological Model for Biliary Atresia.Bile acid synthesis and excretion following release of total extrahepatic cholestasis by percutaneous transhepatic drainage.Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders.Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.Enzymatic sulphation of bile salts in man.Biological and medical aspects of active ileal transport of bile acids.Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.The patterns of glycine and taurine conjugates of bile acids in serum in hepatobiliary disease.Mechanism underlying an elevated serum bile acid level in chronic renal failure patients.
P2860
Q28363481-5254B6B7-9ABE-4387-8659-053FB829AFCBQ34223451-41328DCF-78F8-4258-ADFD-BC2F33598B1CQ34408204-487CC894-25D9-42D3-9363-38805DD99DBCQ34493298-A706609D-B45E-4E57-8F51-3FBF9CBA9C36Q34494527-4892A777-576D-45EC-986B-B7B1E5830540Q35135330-CABC9032-77FA-412B-AA42-FA9987FB4439Q35205903-15D23576-3182-4AC3-9857-B81B4EDF795EQ35216739-5AC5EAE8-D830-45CE-984E-AE22F5C1B305Q35745235-90C1DFAC-54B9-4827-B0A3-CAB98F11C0BBQ36703865-42863440-AB0C-4ADD-AA02-F75B02CDE03AQ36705647-B26FF4C8-9451-48E7-9402-DAAE565B6A33Q37230857-A91820D3-06DB-4392-A71F-2E1742D72BEDQ37365040-4C65F15D-4670-48D1-B27D-4556D72AB678Q37504830-140C1664-ED9A-40D2-97BE-9B406D0DC222Q38648038-3413A576-9118-4439-9964-51FF8A52F488Q39157179-5C204661-EFA7-43E1-B3A1-11772A7DF50DQ39505360-128A33E1-9133-49E6-86A8-DFE65C1F698FQ39704285-B67B86D1-6224-4B27-94A4-36BB43EEF1AFQ39762366-29AAE87C-958A-4D3D-999B-7A2136CDB2F7Q40209674-1BBD9A5D-1A10-4087-9D19-691F1581E771Q42055741-9A4322F5-C4B3-46F0-A70F-A83279329E19Q42105636-26FD72D3-23D3-4BF0-A66E-89249EC40686Q42257233-D81DC57C-5723-4C44-82A9-CFC6135426C9Q42270485-1462A49A-8F83-441A-BE04-97C20DB65BD0Q42273477-646E3DE5-CABE-4263-91F4-FAC0AE5C03E1Q42703776-21220026-20AD-43BC-AB8D-93A79EF5AC6EQ42744337-BAD8A2D2-84D8-49FF-878C-2213C1F6F882Q44749766-C8FBABE4-A820-4E8D-B9ED-DB5B780848D1Q44832374-5046F0A0-0D6B-4E5A-8A70-F157B7DF7A14Q51155778-1CB41FD9-2084-4D35-9706-4717D9E5B076Q51649532-5CA19BE4-6130-4F9F-8FB9-33D514FA8018Q53659466-C90D1BC9-A2CB-47E9-A96F-28D77DC48636
P2860
Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.
description
1976 nî lūn-bûn
@nan
1976 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
name
Sulphated and unsulphated bile ...... e of patients with cholestasis
@nl
Sulphated and unsulphated bile ...... of patients with cholestasis.
@ast
Sulphated and unsulphated bile ...... of patients with cholestasis.
@en
type
label
Sulphated and unsulphated bile ...... e of patients with cholestasis
@nl
Sulphated and unsulphated bile ...... of patients with cholestasis.
@ast
Sulphated and unsulphated bile ...... of patients with cholestasis.
@en
prefLabel
Sulphated and unsulphated bile ...... e of patients with cholestasis
@nl
Sulphated and unsulphated bile ...... of patients with cholestasis.
@ast
Sulphated and unsulphated bile ...... of patients with cholestasis.
@en
P2093
P2860
P356
P1433
P1476
Sulphated and unsulphated bile ...... of patients with cholestasis.
@en
P2093
Parmentier G
van Berge Henegouwen GP
P2860
P304
P356
10.1136/GUT.17.11.861
P407
P577
1976-11-01T00:00:00Z